← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Creighton University
Omaha, NE
$206,577,503
Total funding
242
Grants
Funding over time
peak $19.9M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$183,114,814 · 202
DOE$9,120,110 · 5
DOD$5,981,540 · 12
NSF$5,889,511 · 19
AHRQ$1,978,602 · 3
CDC$492,926 · 1
By mechanism
R01$126,093,128 · 85
—$20,991,161 · 36
P20$11,989,130 · 18
R21$9,876,350 · 28
U01$8,728,257 · 3
R15$6,974,959 · 19
Investigators at Creighton University
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
A STUDY OF RELATIVISTIC HEAVY ION COLLISIONS$3,686,000
· FY2010 · Department of Energy
Mycotoxins and Birth Defects: A Global Health Concern?$2,715,666
RC4 · FY2010 · HD
TAS::89 0321::TAS CREIGHTON UNIVERSITY TRAINING & RESEARCH IN SOLAR POWER$2,400,000
· FY2010 · Department of Energy
Translational Hearing Center$2,263,327
P20 · FY2021 · GM
Translational Hearing Center$2,175,101
P20 · FY2024 · GM
Translational Hearing Center$2,160,551
P20 · FY2025 · GM
Translational Hearing Center$2,138,181
P20 · FY2022 · GM
Translational Hearing Center$2,116,006
P20 · FY2023 · GM
CONSTRUCTION OF RESEARCH FACILITY$2,000,000
C06 · FY2002 · RR
Administrative Core$1,627,589
P20 · FY2024 · GM
A STUDY OF ULTRA-RELATIVISTIC HEAVY ION COLLISIONS$1,477,000
· FY2008 · Department of Energy
SMALL MOLECULE THERAPEUTICS FOR HAIR CELL REGENERATION AFTER NOISE DAMAGE$1,400,942
· FY2018 · Defense Health Agency
Administrative Core$1,158,996
P20 · FY2025 · GM
ALTERNATIVE ENERGY FOR HIGHER EDUCATION$1,141,800
· FY2010 · Department of Energy
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women$866,424
R01 · FY2010 · CA
Administrative Core$859,905
P20 · FY2022 · GM
Administrative Core$847,201
P20 · FY2023 · GM
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women$829,004
R01 · FY2009 · CA
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$794,879
R01 · FY2015 · HL
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$779,682
R01 · FY2014 · HL